Logo image of AREIT.PA

ALTAREIT (AREIT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:AREIT - FR0000039216 - Common Stock

515 EUR
0 (0%)
Last: 1/2/2026, 7:00:00 PM
Fundamental Rating

2

AREIT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 70 industry peers in the Real Estate Management & Development industry. AREIT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AREIT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AREIT has reported negative net income.
AREIT had a positive operating cash flow in the past year.
In multiple years AREIT reported negative net income over the last 5 years.
Of the past 5 years AREIT 4 years had a positive operating cash flow.
AREIT.PA Yearly Net Income VS EBIT VS OCF VS FCFAREIT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.86%, AREIT is doing worse than 64.29% of the companies in the same industry.
Looking at the Return On Equity, with a value of -8.29%, AREIT is doing worse than 65.71% of the companies in the same industry.
AREIT has a Return On Invested Capital (1.01%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.86%
ROE -8.29%
ROIC 1.01%
ROA(3y)-2.85%
ROA(5y)-1.06%
ROE(3y)-14.57%
ROE(5y)-5.87%
ROIC(3y)N/A
ROIC(5y)N/A
AREIT.PA Yearly ROA, ROE, ROICAREIT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

AREIT has a Operating Margin of 0.92%. This is in the lower half of the industry: AREIT underperforms 61.43% of its industry peers.
In the last couple of years the Operating Margin of AREIT has declined.
AREIT has a worse Gross Margin (16.64%) than 64.29% of its industry peers.
In the last couple of years the Gross Margin of AREIT has declined.
Industry RankSector Rank
OM 0.92%
PM (TTM) N/A
GM 16.64%
OM growth 3Y-51.05%
OM growth 5Y-32.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-5.31%
AREIT.PA Yearly Profit, Operating, Gross MarginsAREIT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AREIT is destroying value.
The number of shares outstanding for AREIT remains at a similar level compared to 1 year ago.
The number of shares outstanding for AREIT remains at a similar level compared to 5 years ago.
Compared to 1 year ago, AREIT has a worse debt to assets ratio.
AREIT.PA Yearly Shares OutstandingAREIT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
AREIT.PA Yearly Total Debt VS Total AssetsAREIT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.38, we must say that AREIT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.38, AREIT is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
The Debt to FCF ratio of AREIT is 4.56, which is a neutral value as it means it would take AREIT, 4.56 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.56, AREIT belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
AREIT has a Debt/Equity ratio of 0.96. This is a neutral value indicating AREIT is somewhat dependend on debt financing.
The Debt to Equity ratio of AREIT (0.96) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 4.56
Altman-Z 1.38
ROIC/WACC0.17
WACC5.94%
AREIT.PA Yearly LT Debt VS Equity VS FCFAREIT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

AREIT has a Current Ratio of 1.22. This is a normal value and indicates that AREIT is financially healthy and should not expect problems in meeting its short term obligations.
AREIT's Current ratio of 1.22 is in line compared to the rest of the industry. AREIT outperforms 47.14% of its industry peers.
A Quick Ratio of 0.74 indicates that AREIT may have some problems paying its short term obligations.
The Quick ratio of AREIT (0.74) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.74
AREIT.PA Yearly Current Assets VS Current LiabilitesAREIT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.87% over the past year.
The Revenue has decreased by -6.91% in the past year.
AREIT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.00% yearly.
EPS 1Y (TTM)81.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.27%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-4.16%
Revenue growth 5Y-3%
Sales Q2Q%-23.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AREIT.PA Yearly Revenue VS EstimatesAREIT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

4. Valuation

4.1 Price/Earnings Ratio

AREIT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AREIT.PA Price Earnings VS Forward Price EarningsAREIT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AREIT is valued a bit cheaper than the industry average as 64.29% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AREIT is valued cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.99
EV/EBITDA 19.95
AREIT.PA Per share dataAREIT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800 1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AREIT!.
Industry RankSector Rank
Dividend Yield 0%

ALTAREIT

EPA:AREIT (1/2/2026, 7:00:00 PM)

515

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-29 2025-07-29
Earnings (Next)02-23 2026-02-23
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.85%
Ins Owner ChangeN/A
Market Cap901.25M
Revenue(TTM)2.22B
Net Income(TTM)-59.10M
Analysts78
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF 4.99
P/OCF 3.76
P/B 1.26
P/tB 2.35
EV/EBITDA 19.95
EPS(TTM)-33.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)103.2
FCFY20.04%
OCF(TTM)137.14
OCFY26.63%
SpS1269.89
BVpS408
TBVpS218.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.86%
ROE -8.29%
ROCE 1.63%
ROIC 1.01%
ROICexc 1.15%
ROICexgc 1.55%
OM 0.92%
PM (TTM) N/A
GM 16.64%
FCFM 8.13%
ROA(3y)-2.85%
ROA(5y)-1.06%
ROE(3y)-14.57%
ROE(5y)-5.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-39.62%
ROICexgc growth 5Y-25.24%
ROICexc growth 3Y-44.47%
ROICexc growth 5Y-28.6%
OM growth 3Y-51.05%
OM growth 5Y-32.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.03%
GM growth 5Y-5.31%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 4.56
Debt/EBITDA 10.43
Cap/Depr 132%
Cap/Sales 2.67%
Interest Coverage 0.3
Cash Conversion 366.97%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.74
Altman-Z 1.38
F-Score6
WACC5.94%
ROIC/WACC0.17
Cap/Depr(3y)26.66%
Cap/Depr(5y)37.51%
Cap/Sales(3y)0.42%
Cap/Sales(5y)0.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-4.16%
Revenue growth 5Y-3%
Sales Q2Q%-23.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y106.45%
EBIT growth 3Y-53.08%
EBIT growth 5Y-34.47%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.41%
FCF growth 3Y75.91%
FCF growth 5Y6.02%
OCF growth 1Y127.49%
OCF growth 3Y70.55%
OCF growth 5Y7.83%

ALTAREIT / AREIT.PA FAQ

What is the ChartMill fundamental rating of ALTAREIT (AREIT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AREIT.PA.


Can you provide the valuation status for ALTAREIT?

ChartMill assigns a valuation rating of 2 / 10 to ALTAREIT (AREIT.PA). This can be considered as Overvalued.


Can you provide the profitability details for ALTAREIT?

ALTAREIT (AREIT.PA) has a profitability rating of 1 / 10.


What is the financial health of ALTAREIT (AREIT.PA) stock?

The financial health rating of ALTAREIT (AREIT.PA) is 4 / 10.